Atlas Trials

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

Clinical trial NCT00621998 · COMPLETED

Trial details

NCT number
NCT00621998
Sponsor
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Neuroleptic-Induced Tardive Dyskinesia
Start date
2000-07-01
Primary completion
2003-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.